XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (Q3) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2015   5,042    
Beginning balance at Dec. 31, 2015 $ (9,944) $ 5 $ 298,926 $ (308,875)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 1,747   1,747  
Issuance of common stock and warrants (in shares)   2,691    
Issuance of common stock and warrants 7,865 $ 3 7,862  
Net income (loss) (7,433)     (7,433)
Ending balance (in shares) at Dec. 31, 2016   7,733    
Ending balance at Dec. 31, 2016 (7,516) $ 8 308,784 (316,308)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 1,138   1,138  
Issuance of common stock due to the vesting of restricted stock, net of shares withheld to cover taxes (in shares)   131    
Issuance of common stock and warrants (in shares)   7,353    
Issuance of common stock and warrants 10,733 $ 7 10,726  
Issuance costs related to common stock and warrants (1,392)   (1,392)  
Amendment of equity classified warrants 289   289  
Reclassification of warrant liabilities to equity 798   798  
Net income (loss) 321     321
Ending balance (in shares) at Dec. 31, 2017   15,217    
Ending balance at Dec. 31, 2017 4,371 $ 15 320,343 (315,987)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense 985   985  
Issuance of common stock due to the vesting of restricted stock, net of shares withheld to cover taxes (in shares)   181    
Proceeds from exercise of warrants (in shares)   1,041    
Proceeds from exercise of warrants 1,275 $ 1 1,274  
Issuance of common stock and warrants (in shares)   11,700    
Issuance of common stock and warrants 4,792 $ 12 4,780  
Issuance costs related to common stock and warrants (689)   (689)  
Amendment of equity classified warrants 293   293  
Reclassification of warrant liabilities to equity 472   472  
Net income (loss) (7,386)     (7,386)
Ending balance (in shares) at Sep. 30, 2018   28,139    
Ending balance at Sep. 30, 2018 $ 4,113 $ 28 $ 327,458 $ (323,373)